Have a personal or library account? Click to login
Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors Cover

Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors

Radiology and Oncology
Volume 51 (2017): Issue 3 (September 2017)
By: Matjaz Zwitter,  Antonio Rossi,  Massimo Di Maio,  Maja Pohar Perme and  Gilberto Lopes  
Open Access
|Jul 2017

Authors

Matjaz Zwitter

matjaz.zwitter@guest.arnes.si

Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Maribor, Maribor, Slovenia

Antonio Rossi

Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG), Italy

Massimo Di Maio

Division of Medical Oncology, Mauriziano Hospital, Oncology Department, University of Turin, Torino, Italy

Maja Pohar Perme

Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Gilberto Lopes

Centro Paulista de Oncologia e HCor Onco, members of the Oncoclinicas do Brasil Group, Sao Paulo, Brazil and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
DOI: https://doi.org/10.1515/raon-2017-0029 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 241 - 251
Submitted on: May 3, 2017
|
Accepted on: Jun 9, 2017
|
Published on: Jul 18, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
NSCLC,
intercalated treatment,
EGFR,
tyrosine-kinase inhibitors
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2017 Matjaz Zwitter, Antonio Rossi, Massimo Di Maio, Maja Pohar Perme, Gilberto Lopes, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 51 (2017): Issue 3 (September 2017)Next article